Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02389244
Title A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas (REGOBONE)
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications

chordoma

chondrosarcoma

Ewing sarcoma of bone

osteosarcoma

bone sarcoma

Therapies

Regorafenib

Age Groups: adult | child | senior
Covered Countries FRA


No variant requirements are available.